IL18 polymorphism is associated with an increased risk of crohn's disease

Journal of Gastroenterology

Volumn 37, Issue SUPPL. 14, 2002, Pages 111-116

  Tamura, Kazuo ^a   Fukuda, Yoshihiro ^a   Sashio, Hiroko ^a   Takeda, Naohisa ^a   Bamba, Hiroko ^a   Kosaka, Tadashi ^a   Fukui, Shin ^a   Sawada, Koji ^a   Tamura, Kazutami ^a   Satomi, Misamichi ^a   Yamada, Takahiro ^a   Yamamura, Takehira ^a   Yamamoto, Yoshihiro ^a   Furuyama, Jun Ichi ^a   Okamura, Haruki ^a   Shimoyama, Takashi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Crohn's disease; Genetic susceptibility; IL18; Ulcerative colitis

Indexed keywords

INTERLEUKIN 18;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CODON; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DNA SEQUENCE; ENTERITIS; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC CODE; GENETIC PREDISPOSITION; GENETIC RISK; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

EID: 0036854732     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03326428     Document Type: Article

References (29)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1997; 325:928-37, 1008-16.
2. Orhlolm M, Munkholm P, Langholz E, Nielsen OH, Sørensen TIA, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991;324:84-8.
3. Satsangi J, Jewell DP, Rosenberg WMC, Bell JI. Genetics of inflammatory bowel disease. Gut 1994;35:696-700.
4. Tysk C, Lindberg E, Jänerot G, Flodérus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:990-6.
5. Roth M-P, Petersen GM, McElree C, Vadheim CM, Panish JF, Rotter J. Familial empiric risk estimates of inflammatory bowel disease in Ashkenasi Jews. Gastroenterology 1989;96:1016-20.
6. Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut 1996;38:738-41.
7. Hugot J-P, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (Lond) 1996:379:821-3.
8. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosome 3, 7, 12. Nat Genet 1996:14:199-202.
9. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, Rohal PM. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA 1998;95:7502-7.
10. Bioque G. Koutroubakis CI, Bouma G, Kostense PJ, Meuwissen SGM, Peña AS. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995;102:379-83.
11. Nemetz A, Nosti-Escanilla MP, Molnár T, Köpe A, Kovács Á, Fehér J, et al. IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 1999;49: 527-31.
12. Negoro K, Kinouchi Y, Hiwatashi N, Takahashi S, Takagi S, Satoh J, et al. Crohn's disease is associated with polymorphism in the 5′-flanking region of the tumour necrosis factor gene. Gastroenterology 1999:117:1062-8.
13. Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 1995;109:1462-7.
14. Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996:347:1212-7.
15. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature (Lond) 1995:378:88-91.
16. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates th1 and th2 responses. Annu Rev Immunol 2001;19: 423-74.
17. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, et al. Activation of interferon-γ-inducing factor mediated by interieukin-1β converting enzyme. Science 1997;275:206-9.
18. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature (Lond) 1997:386:619-23.
19. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, et al. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 1996;156:4274-9.
20. Nolan KF, Greaves DR, Waldmann H. The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics 1998:51:161-3.
21. Tsutsui H, Matsui K, Okamura H, Nakanishi K. Pathophysiology of interleukin-18 in inflammatory liver disease. Immunol Rev 2000;174:192-209.
22. Takeuchi M, Nishizaki Y, Sano O, Ohta T, Ikeda M, Kurimoto M. Immunohistochemical and immuno-electron-microseopic detection of interferon-γ-inducing factor ("interleukin-18") in mouse intestinal epithelial cells. Cell Tissue Res 1997:289:499-503.
23. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. Regulation of interferon-γ production by IL-12 and IL-18. Curr Opin Immunol 1998;10:259-64.
24. Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith Jr MF, Foley E, et al. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol 1999;162:6829-35.
25. Monteleone G, Trapasso F, Parello T, Biancone L, Stella A, Iuliano R, et al. Bioactive IL-18 expression is up-regulated in Crohn's disease. J Immunol 1999:163:143-7.
26. Kanai T, Watanabe M, Okazawa A, Nakamaru K, Okamoto M, Naganuma M, et al. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease. Gastroenterology 2000;119:1514-23.
27. Saeki Y, Tamura, K, Yamamoto Y, Hatada T, Furuyama J, Utsunomiya J. Germline p53 mutation at codon 133 in a cancer-prone family. J Mol Med 1997;75:50-6.
28. Morita N, Toki S, Hirohashi T, Minoda T, Ogawa K, Kono S, et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol 1995;30(suppl VIII):1-4.
29. Carter CO. Genetic common disorders. Br Med Bull 1969;25:52-7.